The 42nd International Symposium on the Separation of Proteins, Peptides and Polynucleotides (ISPPP 2023) took place this year from 5 to 8 November 2023 in Vienna (Austria).

As part of a new case study (outside the project plans) testing the OF2i technology developed in NanoPAT with polymers, our colleague Usue Aspiazu from UPV/POLYMAT (Spain) is visiting our colleagues from BRAVE Analytics for a few months

We are very happy to announce that the BRAVE’s nanoparticle analyser, BRAVE B-Curious, has been awarded second place in the category “Separation, Lab Automation & Lab Equipment”.

Our colleagues from PDW Analytics and University of Potsdam (namely Justin Aaron Koenig (UP), Tobias Simon (PDWA) and Sebastian Zimmermann (UP) visited our industrial partner Evonik in Wesseling (Germany) from 9th till 20th October 2023.

The Leverage of IT for Engineering and Science (LITES) conference 2023 took hybrid place on 30 Oct. – 1 Nov. 2023 in the beautiful Istanbul (Türkiye).

On 20th October 2023, Blanca Suarez, from TEMASOL, visited the brand new facilities of FLUIDINOVA in Porto (Portugal), where BRAVE Analytics installed their OF2i B-Continuous prototype in one of Fluidinova’s nanohydroxyapatite reactors (as reported here).

Blanca was introduced to their pilot line using the OF2i device and all equipment involved, as part of TEMASOL activities in Task 7.4 “Nanosafety assessment & Elaboration of safety/Safety-by-Design guidelines”. The process is currently being analysed by TEMASOL staff under a risk assessment perspective to identify potential health issues, focusing on occupational exposure and nanosafety. The strategy will follow the one developed in the EU-H2020 project NanoReg2 for Safety-by-Design (SbD) implementation in industrial settings but adapted to the particulars of NanoPAT processes.

With this visit TEMASOL contributes to the SbD concept of the project, anticipating, identifying and addressing future safety issues relevant for commercially fully exploitable innovative technologies.

On 23 October 2023, our colleagues from BNN organised a Standardisation Workshop for NanoPAT’s technology developers, to get an overview of the meaning of standardisation, how it can be used and how NanoPAT and its partners can standardise their technologies.

The aim of the workshop is to hear an overall introduction to standardisation by Dr. Denis Koltsov (Director of BREC Solutions, Limited and chair of ISO TC229 (Nanotechnologies)) and to present NanoPAT technologies. A joint discussion about the impact of a standardised technology / service will be held between Dr.

Kolstov and NanoPAT technology developers.

The workshop was hosted at BNN office in Graz and counted with online and on-site of all technology providers (PDWA, BRAVE, IRIS) plus TEMASOL, as leader of the project task on standardisation. As always when partners come together, we took the chance to network and interchange experiences and knowledge.

Special thanks to Denis Koltsov, who came to Graz especially for this occasion and enriched us with his knowledge and experience.

On 24 October, Denis visited BRAVE facilities to get a better overview about the OF2i technology, in theory and in praxis, with a lab-tour and being able to see the B-continuous (B1-PAT device) and the B-curious (B2-Lab device) in real life.

On 12-13 October 2023 took place, for the first time ever, the BioTech Summit Austria in Graz (Austria). The summit aimed to facilitate networking and exchange of ideas on trends in the biotech and pharmaceutical world, how to succeed as a startup and SME, funding and financing opportunities, how to navigate the regulations and the best road to clinical trials.
The event was jointly organised by BIOTECH AUSTRIA, the pioneering association of the biotechnology industry in Austria, and den life science cluster organisation Human.technology Styria (HTS) at the Medical University Graz, bringing together around 350 people, including key players of the Austrian and international biotech industry.

Our colleagues from BRAVE Analytics didn’t miss this fantastic opportunity of networking with similar companies and big players! Vitan Strasser gave a 3min pitch on OF2i technology’ benefits to biotech and pharma companies, highlighting how OF2i can improve work routines and results. Additionally, BRAVE had a booth, where Vitan Strasser and Sarah Knights where able to meet very interesting companies for further businesses.

Last month (6th to 13th September 2023), colleagues from BRAVE Analytics visited FLUIDINOVA facilities in Porto (Portugal) to perform the installation of the OF2i B-Continuous prototype at their hydroxyapatite production site.
FLUIDINOVA’s nano-hydroxyapatite particles are one of NanoPAT’s case studies. With the BRAVE B1 device, they will now be able to characterize nano-hydroxyapatite particles at different stages of their production, using the innovative OF2i technology developed by BRAVE.
The first days of the visit were dedicated to the assemble and calibration of the equipment by BRAVE. In the following days, they performed the connection of the device to FLUIDINOVA tanks. The connection was perfect and they were able to do some preliminary measurements.
BRAVE team trained the FLUIDINOVA team to operate the OF2i equipment by themselves, as FLUIDINOVA will use the OF2i sensor on a daily basis for next weeks to make measurements on different product batches and different states of our production, to get as much information as possible.

All in one, it was a very successful week, where both teams had the chance to learn more about their technologies and processes. As add on, the had a great time together!
Looking forward to the interesting results in the upcoming weeks!

From 26 to 28 September 2023, took place in Basel (Switzerland), The largest Swiss trade fair for international laboratory, measurement and automation technology in chemistry, the ILMAC 2023.
Around 12000 people attended the international conference.
Our colleague Vitan Strasser, from BRAVE Analytics, gave a talk on OF2i technology, highlighting several real uses cases, commenting on the benefits for the users and how OF2i technology can support global biotech and nanopollutant players as this PAT offers real-time nanoparticle characterisation, measurement of nanopollutants at ultra-low concentrations, and many more! Additionally, on their booth, Vitan was able to network with a number or interesting companies.